NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/28/2022
Back to search
Official data from USPTO
RESOLUTION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RESOLUTION
ST13
US500000090130276Class
1, 5, 40, 42, 44
Filing
90130276
Registration
6770463
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
06/28/2022
Trademark type
Word
Nice classes
1, 5, 40, 42, 44
Filing date
08/21/2020
Registration date
06/28/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/28/2022
Last transaction
06/28/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
London, GB
Examiner
MUNN LEWIS, LAKEISHA
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Resolution Therapeutics Limited
Representatives
Rebecca Liebowitz VENABLE LLP
Technical classification
Nice Classes
Class 1Class 5Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Cells for scientific purposes; molecular biology research tools in the nature of biologicalchemical and biochemical reagents for research use; biological preparations for cell therapy
Class 5
Pharmaceutical preparations for the treatment of hematologic diseasesimmune response disordersneurological disordersrespiratory diseasesophthalmological conditionsmetabolic diseasesgenetic conditionscancerinfectious diseases and cardiovascular diseases; medical and veterinary preparations for therapeutic purposes for the treatment of hematologic diseasesimmune response disordersneurological disordersrespiratory diseasesophthalmological conditionsmetabolic diseasesgenetic conditionscancerinfectious diseases and cardiovascular diseases; cells for medical or veterinary use; pharmaceutical and biopharmaceutical preparations for modifying human or animal cells for medical or therapeutic purposes; pharmaceutical and biopharmaceutical preparations of cells from humans or animals which have been adapted for medical or therapeutic purposes
Class 40
Treatment and processing of biological materials; custom manufacture of therapeutic drugscustom manufacture of cells and cell therapies
Class 42
Scientific and technological services and research and design relating theretoscientific research in the field of in the fields of haematologyimmunologyneurologyrespiratory diseasesophthalmologymetabolic conditionsgenetic conditionsoncologyimmuno-oncologyinfectious diseases and cardiovascular diseases; industrial research servicesin the field of cell therapies and gene therapies; chemical and biological analysis and research services; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; design and development of new products for others; scientific laboratory servicesmanipulation of human and animal cells for therapeutic purposes ; advisory and consultancy relating to all the aforesaid services
Class 44
Medical and veterinary research services including the manipulation of biological reagents to be used for medical or therapeutic purposes; medical and veterinary research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; veterinary services; medical services in the nature of extraction of human and animal cells from patients; medical servicesreinsertion of cells into human and animal patients; providing advice and consultancy in the field of medical and veterinary therapies
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/28/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/12/2022
PUBO
PUBLISHED FOR OPPOSITION
04/12/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/23/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/07/2022
ALIE
ASSIGNED TO LIE
02/02/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/26/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/27/2021
GNRT
NON-FINAL ACTION E-MAILED
07/27/2021
CNRT
NON-FINAL ACTION WRITTEN
07/27/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/24/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/24/2021
ALIE
ASSIGNED TO LIE
06/24/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/14/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/21/2020
GNRT
NON-FINAL ACTION E-MAILED
12/21/2020
CNRT
NON-FINAL ACTION WRITTEN
12/21/2020
DOCK
ASSIGNED TO EXAMINER
12/17/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/24/2020
NWAP
NEW APPLICATION ENTERED
08/25/2020
Continuous trademark protection
Get notified about every new filing that threatens RESOLUTION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.